MedPath
FDA Approval

EVEROLIMUS

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Biocon Pharma Inc.
DUNS: 080000063
Effective Date
June 2, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Everolimus(7.5 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Biocon Pharma Limited

871412155

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Biocon Limited

Biocon Pharma Inc.

Biocon Pharma Limited

915076162

Biocon Pharma Limited

Biocon Pharma Inc.

Biocon Pharma Limited

871412155

Products4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

EVEROLIMUS

Product Details

NDC Product Code
70377-012
Application Number
ANDA214182
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 2, 2023
Code: 9HW64Q8G6GClass: ACTIBQuantity: 7.5 mg in 1 1
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171KClass: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
HYPROMELLOSE 2208 (3 MPA.S)Inactive
Code: 9H4L916OBUClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

EVEROLIMUS

Product Details

NDC Product Code
70377-010
Application Number
ANDA214182
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 2, 2023
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171KClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
HYPROMELLOSE 2208 (3 MPA.S)Inactive
Code: 9H4L916OBUClass: IACT
Code: 9HW64Q8G6GClass: ACTIBQuantity: 2.5 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT

EVEROLIMUS

Product Details

NDC Product Code
70377-013
Application Number
ANDA214182
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 2, 2023
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
HYPROMELLOSE 2208 (3 MPA.S)Inactive
Code: 9H4L916OBUClass: IACT
Code: 9HW64Q8G6GClass: ACTIBQuantity: 10 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171KClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT

EVEROLIMUS

Product Details

NDC Product Code
70377-011
Application Number
ANDA214182
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 2, 2023
Code: 9HW64Q8G6GClass: ACTIBQuantity: 5 mg in 1 1
HYPROMELLOSE 2208 (3 MPA.S)Inactive
Code: 9H4L916OBUClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMKClass: IACT
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171KClass: IACT
CROSPOVIDONEInactive
Code: 2S7830E561Class: IACT
© Copyright 2025. All Rights Reserved by MedPath